Hepatitis Monthly

Published by: Kowsar

A Placebo-Controlled Trial of Silymarin in Patients with Nonalcoholic Fatty Liver Disease

Seyed Jalal Hashemi 1 , Eskandar Hajiani 2 , * and Ebrahim Haidari Sardabi 1
Authors Information
1 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Emam Hospital, Ahvaz Jundishapur University of Medical Sciences, Khoozestan, IR.Iran
2 Division of Gastroenterology and Hepatology, Department of Internal Medicine, Emam Hospital, Ahvaz Jundishapur University of Medical Sciences, ehajiani@ajums.ac.ir, Khoozestan, IR.Iran
Article information
  • Hepatitis Monthly: 9 (4); 265-270
  • Article Type: Research Article
  • Received: April 26, 2009
  • Accepted: November 9, 2009

To Cite: Hashemi S, Hajiani E, Sardabi E. A Placebo-Controlled Trial of Silymarin in Patients with Nonalcoholic Fatty Liver Disease, Hepat Mon. Online ahead of Print ; 9(4):265-270.

Abstract
© 0, Author(s). This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
Full Text
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments